drugset / Trial / NCT04135937

Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)

NCT04135937

Phase 4 Completed 12 enrolled VA Office of Research and Development
NaSingle-groupOpen-labelTreatment

Summary

Smoking is a significant cause of damage to health and quality of life specifically for Veterans with human immunodeficiency virus (HIV). Smoking cessation interventions for this population are lacking. The primary aim of this project is to explore smoking cessation treatment preferences among Veteran smokers living with HIV. The study team will refine the design and content of a smoking cessation treatment for Veteran smokers living with HIV. The intervention uses mobile health and telehealth technology to personalize smoking cessation counseling and medications and provide relapse prevention text messaging.

Timeline

Start
2019-11-18
Primary completion
2021-07-15
Completion
2021-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Varenicline Small molecule